Gilles de la Tourette syndrome (TS) is a neuropsychiatric disorder characterized by both motor and vocal tics. Individuals with TS often have symptoms of obsessive compulsive disorder (OCD) and these symptoms are thought to be an alternative expression of the TS gene(s) in TS families. In this paper we test for linkage of the functional polymorphism in the catechol-Omethyltransferase (COMT) gene to TS and OCD in five multi-generational families ascertained through a TS proband. This polymorphism (valine to methionine at codon 158) has been previously reported to influence the activity of COMT by three to four-fold and has recently been reported to be associated with OCD.
The defining characteristics of TS are both motor and phonic tics but other phenotypes are commonly seen in TS individuals and their family members including chronic multiple tics (CMT) [2] [3] [4] [5] and obsessive compulsive disorder (reviewed in 6 ). Segregation studies support the proposition that these two phenotypes represent an alternative expression of a TS susceptibility gene(s) (see for example 2, 3 ). Also of note is the observation in TS pedigrees that males are more likely to have TS or tics, while females are more likely to have OCD or obsessive compulsive symptoms. 3 There is robust evidence of dopaminergic overactivity in TS, since agents that block dopamine (neuroleptics) relieve the symptoms of tics and agents that increase dopamine levels, such as stimulants, can aggravate tics (reviewed in 7 ) . The COMT gene is an attractive candidate for a genetic etiological factor in TS as this enzyme is involved in the inactivation of both dopamine and norepinephrine. One could therefore hypothesize that a reduction in the activity of COMT would result in an increase of dopamine levels and influence the predisposition to the expression of tics.
A genetic polymorphism has been identified in the COMT gene that determines the level of activity and the thermal stability. 8 About one quarter of Caucasians have been found to have low COMT activity, one quarter to have high activity, and the remainder to have intermediate activity. This change in enzyme activity level identified in red blood cells was found to be explained by a sequence change (G to A) at codon 158 with the high activity allele coding for valine and the low activity allele coding for methionine at this site. 8 This polymorphism can be easily detected by a change in the restriction site for the enzyme NlaIII 9 allowing for determination of the high and low activity alleles.
A recent study examined the role of this gene in OCD using a case-control association approach. 1 This study examined 73 subjects with OCD and compared the allele and genotype frequencies to 148 ethnically matched Caucasian controls. Eighteen of the 68 subjects who were screened for tics, were identified as having comorbid tics (13 males and five females). A significant association was reported for the presence of the low activity Met 158 genotype and OCD. Interestingly when the subjects were divided by sex, the genotypic association was found to be more strongly correlated with male subjects than female (P = 0.0002 vs P = 0.0658). The basis for the author's division by sex was the previous finding of dimorphic expression of COMT in both mice 10 and humans. 11 The finding from the recent creation of mice deficient for COMT 10 showed differences in regional expression in dopamine levels, in particular in the frontal cortex. In mice homozygous for the disrupted COMT gene there was a two to three-fold increase in dopamine levels in the frontal cortex of males but not in females. There were no changes in either sex in the expression of dopamine in the hypothalamus or striatum.
The COMT gene is therefore an attractive candidate for the genetic etiological factor in TS both because of its role in catecholamine inactivation, the reported association with OCD, and because of the dimorphic and regional specific expression of the gene.
In this study we tested for linkage of the functional polymorphism at codon 158 in COMT (Val or Met) and the TS/CMT, and OCD phenotypes in pedigrees ascertained via a TS proband. We tested for linkage in five multi-generational families. Simulation studies of these families have shown that these families have power to independently provide evidence for linkage given that a sufficiently informative marker is used. No evidence for linkage was found using an autosomal dominant model with reduced penetrance in any of the pedigrees or with either of the affected classifications. The results from the linkage analysis are reported in Table 1 . Using the autosomal dominant model we were able to exclude the COMT locus in only one family (T005). The summed exclusion for all five pedigrees, excluded the COMT locus and 5 cM on either side of the locus. There was no evidence for linkage with either of the two nonparametric tests in any of the pedigrees or with either affected classification of phenotype (Table 1) . Although there has been preliminary evidence suggesting the genetic contribution of the COMT functional polymorphism to the phenotype of OCD, 1 we found no evidence for linkage to the TS/CMT or OCD phenotype in the families investigated in this study. The use of the autosomal dominant model supported by segregation studies and the nonparametric methods that evaluate allele sharing among affected individuals should allow us to detect linkage of the COMT gene in these pedigrees. Our study confirms previous findings of normal COMT activity in TS patients using small (n = 5 and n = 24) sample sizes. 12, 13 Another argument against the role of COMT in TS and tic disorders, can be derived from the behaviors observed in patients with velo-cardio-facial syndrome (VCFS) a hemizygous deletion syndrome of the 22q11 chromosomal region, 14 the location of the COMT gene. 15 Patients with VCFS have been observed to have an increased prevalence of psychiatric disorders including bipolar spectrum disorder, attention-deficit hyperactivity disorder, and OCD but no observation of an increase in the prevalence of tics or TS has been reported. In addition an association has been reported with the low activity allele in patients with VCFS and bipolar spectrum disorder, and in particular, a rapidcycling form. 9 No increase in tics or TS was reported in these VCFS patients with low COMT activity, suggesting that low COMT activity is not related to the TS or tic phenotypes in VCFS patients.
There has been some suggestion in the literature that OCD in individuals with TS and/or a family history of tics may have a different etiology than families with OCD alone. This suggestion is based on treatment response, age at onset, symptom profile, sex, family history, neurochemical and neuroendocrine findings (reviewed in 16 ). The most interesting evidence comes from differential treatment response of OCD patients with tics. These patients often do not respond to selective serotonin reuptake inhibitors alone and the addition of neuroleptics has been found to be effective in these individuals, 17 suggesting a different etiology of OCD symptoms in individuals with tics. It is therefore possible that the association observed by Karayiorgou et al 1 may be more closely related to the OCD phenotype without tics. Their study included 18 subjects with comorbid tics out of a total subject number of 73 subjects (13 of the 42 males). Because of the small number of OCD subjects with tics in their sample, they were not able to determine if there was an association of COMT in this subsample. They did however note a trend (not significant) for an increased frequency of comorbid tic disorders among males with the Low/Low (Met 158 /Met 158 ) genotype than among males with the 'non-Low/Low' genotype in their sample (46% vs 26%), suggesting that the finding of low COMT activity is similar for OCD with tics in their study.
At this point it is unclear why there would be a discrepancy between the findings in these five families ascertained through a TS proband and the OCD study of Karayiorgou et al. 1 It remains possible that the COMT gene is a susceptibility gene in TS but not in the five families in this study. Another possibility is that the findings of Karayiorgou et al may be a false positive due to a small sample size, in particular once the division of the subjects was made by sex (n = 42 for males and n = 31 for females). Perhaps their finding is related only to OCD without tics or only a subset of OCD with tics. Further studies are required before the determination of the role of this gene in the etiology of OCD should be considered conclusive.
Methods

Diagnosis
Families were assessed using a semistructured interview adapted from the Diagnostic Interview Schedule 18 by a research assistant trained to observe and recognize manifestations of TS and obsessive compulsive disorder (OCD). This interview schedule also includes an extensive section on OCD derived from the Yale-Brown Obsessive Compulsive Scale 19 and provides diagnostic information about attention deficit hyperactivity disorder (ADHD), affective disorder, anxiety disorder, psychosis, antisocial behavior and substance abuse. Additional information regarding current and childhood concentration and hyperactivity was obtained from the diagnostic checklist for ADHD.
Three self-administered instruments were also used: (i) OCD inventory derived from Leyton Obsessive-Compulsive inventory; 20 (ii) SCL 90-a general mental health questionnaire well described in the literature; 21 and (iii) Conner's Parent Rating Scale 22 for children under age 16. All of the above information was reviewed and summarized by an experienced neuropsychiatrist who then derived a diagnostic classification according to the criteria outlined below.
Tourette syndrome was diagnosed according to DSM-III-R 23 criteria and diagnosis was refined as previously suggested, 24 to indicate the quality of the information. Family members were given a possible, probable or definite diagnosis of Tourette syndrome, chronic multiple tic disorder (motor or vocal) or other tic disorders.
This protocol was approved by the Human Subjects Review Committee, The University of Toronto and informed consent was obtained from each person in the study.
Pedigrees
The pedigrees used in this study were collected in Canada, either in the Toronto or Vancouver area and have been previously described. 25 DNA was available and genotyped for the following number of individuals for each of the respective pedigrees; 22 (T001), 15 (T004), 20 (T006), 23 (T005), and 32 (T008). The number of individuals with either TS, CMT or OCD for each pedigree were as follows: 9 (T001), 5 (T004), 12 (T006), 7 (T005), and 13 (T008).
Isolation of DNA and marker typing
Genomic DNA was extracted from whole blood as described. 26 The amplification of the COMT polymorphism was conducted in a buffer containing 1.5 mM MgCl 2 , using the PCR conditions consisting of an initial denaturation of 2 min at 94°C followed by 35 cycles of denaturation at 94°C for 30 s, annealing at 60°C for 30 s, and extension at 72°C for 30 s. The extension was finished with a cycle of 10 min at 72°C. Primers used for the amplification of the polymorphism, COMT-1 5Ј-tcaccatcgagatcaacccc-3Ј and COMT-R 5Ј-gaacgtggtgtgaacacctg-3Ј, produce a fragment of 176 bp. Alleles were identified following electrophoresis on 6% polyacrylamide gels in Tris/Borate/EDTA buffer. The DNA fragments were visualized by silver staining the gels as follows: 5 min in 10% ethanol, 5 min in 1% nitric acid (Fisher Scientific, Pittsburgh, PA, USA), rinsed briefly in double distilled water then stained 20 min in 0.012 M silver nitrate (Sigma, St Louis, MO, USA). After washing for 20 s in double distilled water, the silver was developed in 0.028 Na 2 CO 3 (BDH, Toronto, Canada) and 0.02% formaldehyde (ACP Chemicals, Montreal, Quebec, Canada), then fixed in 1% acetic acid.
Statistical analysis
The parametric linkage analyses were performed using the MLINK program of the LINKAGE package. 27 The following assumptions were incorporated in the genetic model for the parametric analyses: an autosomal dominant gene with gene frequency 0.006. 4 Fourteen liability classes were used to correct for age of onset and sex-related penetrances increasing from age 2 years to 21 years, with a minimum penetrance of 0.048 and a maximum of 0.999 for males and a minimum penetrance of 0.027 and maximum penetrance of 0.561 for females. A small rate of phenocopies was also incorporated into the model: minimum 0.0002 to maximum 0.005 for males and minimum 0 to maximum 0.0001 for females. The small rate of phenocopies (penetrance value for homozygotes for the non-TS allele) is included in the model to compensate for a small rate of false positive diagnoses resulting from environmentally caused symptoms, or the possibility that a second TS susceptibility locus is brought into the pedigree. Haldane's mapping function 28 was used to convert recombination fractions to map distances.
The data were also analyzed nonparametrically using the Affected-Pedigree-Member method (APM) 29 and a modified APM statistic. 30 In the modified method (GPM), the test statistic is extended to include contrast between affected and unaffected pedigree members. 30 For the non-parametric analyses, unaffected family members under 19 years of age were classified as unknown to allow for the possibility of the development of the disorder during the age of risk.
We defined the affected status as first definite and probable TS and definite and probable CMT and then undertook a second analysis where individuals with definite OCD were also classified as affected (individuals with probable OCD were classified as unknown). In the families used in this study, only a few individuals, other than obligate carriers, change from unaffected to affected status with the inclusion of CMT or OCD as affected.
